Axillary Reverse Mapping for Invasive Carcinoma of the Breast
Condition(s):Breast CancerLast Updated:August 2, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:August 2, 2012Completed
Condition(s):Invasive Breast Cancer; Ductal Carcinoma in Situ of the BreastLast Updated:February 21, 2020Unknown status
Condition(s):Arm Lymphedema; Lymphatic Spread of Breast Cancer; Early Breast CancerLast Updated:November 6, 2019Completed
Condition(s):Breast Cancer LymphedemaLast Updated:January 23, 2018Unknown status
Condition(s):Cancer of the BreastLast Updated:March 13, 2024Active, not recruiting
Condition(s):Breast Cancer Stage I; Breast Cancer Stage II; Breast Cancer Stage IIILast Updated:December 8, 2023Active, not recruiting
Condition(s):Lymphedema; Recurrent Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast CancerLast Updated:August 1, 2014Terminated
Condition(s):Breast CancerLast Updated:May 16, 2022Completed
Condition(s):Lymphedema; Breast Cancer; MelanomaLast Updated:October 24, 2023Active, not recruiting
Condition(s):Lymph Node Cancer MetastaticLast Updated:February 28, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.